Cargando…

Innate Immune Cell–Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis

BACKGROUND AND OBJECTIVES: Our aim was to investigate whether 18-kDa translocator protein (TSPO) radioligand binding in gray matter (GM) predicts later disability progression in multiple sclerosis (MS). METHODS: In this prospective imaging study, innate immune cells were investigated in the MS patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misin, Olavi, Matilainen, Markus, Nylund, Marjo, Honkonen, Eveliina, Rissanen, Eero, Sucksdorff, Marcus, Airas, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128041/ https://www.ncbi.nlm.nih.gov/pubmed/35581004 http://dx.doi.org/10.1212/NXI.0000000000001182

Ejemplares similares

TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis
por: Polvinen, Eero, et al.
Publicado: (2023)

Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET
por: Nylund, Marjo, et al.
Publicado: (2021)

Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis
por: Sucksdorff, Marcus, et al.
Publicado: (2020)

Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography
por: Airas, Laura, et al.
Publicado: (2018)

Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging
por: Bezukladova, Svetlana, et al.
Publicado: (2020)

Natalizumab treatment reduces microglial activation in the white matter of the MS brain
por: Sucksdorff, Marcus, et al.
Publicado: (2019)

Synaptic Loss in Multiple Sclerosis: A Systematic Review of Human Post-mortem Studies
por: Möck, E. E. Amelie, et al.
Publicado: (2021)

Association of serum neurofilament light with microglial activation in multiple sclerosis
por: Saraste, Maija, et al.
Publicado: (2023)

High serum neurofilament associates with diffuse white matter damage in MS
por: Saraste, Maija, et al.
Publicado: (2020)

Microglial activation, white matter tract damage, and disability in MS
por: Rissanen, Eero, et al.
Publicado: (2018)

Imaging neuroinflammation in multiple sclerosis using TSPO-PET
por: Airas, Laura, et al.
Publicado: (2015)

In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease
por: Vuorimaa, Anna, et al.
Publicado: (2017)

The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome
por: Cooze, Benjamin J., et al.
Publicado: (2022)

MRI Volumetric Analysis of the Thalamus and Hypothalamus in Amyotrophic Lateral Sclerosis
por: Ye, Shan, et al.
Publicado: (2022)

Diagnosis and treatment of progressive multiple sclerosis: A position paper
por: Pozzilli, Carlo, et al.
Publicado: (2022)

ThalaMS: New Evidence Linking Epilepsy, Multiple Sclerosis, and the Thalamus
por: Beenhakker, Mark P.
Publicado: (2022)

Adenosine A(2A) receptor availability in patients with early- and moderate-stage Parkinson’s disease
por: Waggan, Imran, et al.
Publicado: (2022)

Widespread Glial Activation in Primary Progressive Multiple Sclerosis Revealed by (18)F-PBR06 PET: A Clinically Feasible, Individualized Approach
por: Singhal, Tarun, et al.
Publicado: (2021)

Confirmed disability progression as a marker of permanent disability in multiple sclerosis
por: Sharmin, Sifat, et al.
Publicado: (2022)

Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy
por: Surova, Yulia, et al.
Publicado: (2015)

The cognitive thalamus
por: Saalmann, Yuri B., et al.
Publicado: (2015)

Damage in the Thalamocortical Tracts is Associated With Subsequent Thalamus Atrophy in Early Multiple Sclerosis
por: Weeda, Merlin M., et al.
Publicado: (2020)

MAFLD progression contributes to altered thalamus metabolism and brain structure
por: Nucera, Saverio, et al.
Publicado: (2022)

Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology
por: Barry, Alison, et al.
Publicado: (2016)

Chronic lesion activity and disability progression in secondary progressive multiple sclerosis
por: Beynon, Vanessa, et al.
Publicado: (2022)

Levodopa-Induced Changes in Electromyographic Patterns in Patients with Advanced Parkinson’s Disease
por: Ruonala, Verneri, et al.
Publicado: (2018)

Changes in elbow flexion EMG morphology during adjustment of deep brain stimulator in advanced Parkinson’s disease
por: Ruonala, Verneri, et al.
Publicado: (2022)

What is the Thalamus in Zebrafish?
por: Mueller, Thomas
Publicado: (2012)

Vestibular Interactions in the Thalamus
por: Wijesinghe, Rajiv, et al.
Publicado: (2015)

The Electrophysiology of the Human Thalamus
por: Bates, J. A. V.
Publicado: (1967)

Research progress of the paraventricular thalamus in the regulation of sleep–wake and emotional behaviors
por: Bu, Xiao‐Li, et al.
Publicado: (2022)

Evidence for a two-stage disability progression in multiple sclerosis
por: Leray, Emmanuelle, et al.
Publicado: (2010)

Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2013)

Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis
por: Wiendl, Heinz, et al.
Publicado: (2015)

Long-term disability progression of pediatric-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2019)

Physical activity monitoring to assess disability progression in multiple sclerosis
por: Stuart, Charlotte M, et al.
Publicado: (2020)

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis
por: Cree, Bruce AC, et al.
Publicado: (2020)

Recurrent disability progression endpoints in multiple sclerosis clinical trials
por: Bühler, Alexandra, et al.
Publicado: (2022)

Radiotherapy Improves the Disability in Patients with Secondary Progressive Multiple Sclerosis
por: Ebrahimi, Hossein-Ali, et al.
Publicado: (2023)

Chronotypes and disabling musculoskeletal pain: A Finnish birth cohort study
por: Heikkala, Eveliina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_trt2b7ng1af310hieq6n0tlsuh